From the Desk of the CEO

FDA announced that labeling for opioid analgesics and medications to treat opioid use disorder must now include information about naloxone.

Loren Bonner

From the community, to the hospital, to the classroom, to the airwaves, pharmacists make heroic moves during the pandemic and beyond.

Rachel Balick

When a medication has caused harm, everyone involved with the distribution and use of that medication is potentially accountable for the harm, including any person who abused the medication resulting in that person’s death.

David B. Brushwood, BSPharm, JD

Medicaid managed care companies are working with the Ohio Department of Medicaid to act on a 2019 law that recognizes pharmacists as providers in Ohio.

Loren Bonner

Community pharmacists’ scope of practice is widening during COVID-19, with more patients seeking care from pharmacists and more pharmacies anticipating increased point-of-care testing and expanded immunization services.

Maria G. Tanzi, PharmD